Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
Titel:
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study
Auteur:
Passamonti, Francesco Griesshammer, Martin Palandri, Francesca Egyed, Miklos Benevolo, Giulia Devos, Timothy Callum, Jeannie Vannucchi, Alessandro M Sivgin, Serdar Bensasson, Caroline Khan, Mahmudul Mounedji, Nadjat Saydam, Guray